Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003768022 | SCV001531554 | uncertain significance | Familial adenomatous polyposis 1 | 2023-06-09 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt APC protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 559946). This variant has not been reported in the literature in individuals affected with APC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 2332 of the APC protein (p.Gly2332Ser). |
Ambry Genetics | RCV002360703 | SCV002665396 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-05-07 | criteria provided, single submitter | clinical testing | The p.G2332S variant (also known as c.6994G>A), located in coding exon 15 of the APC gene, results from a G to A substitution at nucleotide position 6994. The glycine at codon 2332 is replaced by serine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
3DMed Clinical Laboratory Inc | RCV000677740 | SCV000803896 | uncertain significance | Sigmoid colon cancer | 2017-03-17 | no assertion criteria provided | clinical testing |